Navigation Links
National Survey Shows Employee Fears About Consumer-Driven Health Plans on Decline
Date:9/12/2007

nses. Once those expenses are paid by the employee any additional expenses are covered 100 percent by the plan for the remainder of the year. Preventative services are covered 100 percent. The monthly premium is $60, or $720 per year. The employee in the example above didn't incur any out-of-pocket expenses because she did not deplete the $1,000 employer-provided fund. This example also included co-insurance of 100 percent. CDH plan designs will differ in their co-insurance and out-of-pocket maximum.

1. Health reimbursement arrangements are plans with accounts owned and

funded by the employer.

2. Health savings accounts are owned by the employee and are funded either

by the employee or with contributions from the employer.


'/>"/>
SOURCE Aon Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. International community warns India on HIV situation
2. Mexico and US border attain a new outlook due to BiNational Sustainability Laboratory
3. National Lung Study in the process
4. Indian Nationals with Foreign Medical Degrees can now practice in India
5. Key step forward on International Health Rules
6. ICMR along with other International Research organisation with drug development for Neglected Diseases
7. International Osteoporosis Research Centre To Be Started In India.
8. Hepatitis B Vaccine To Be Included In National Immunization Programme
9. Indian hospitals require International Accreditation
10. International Conference On Malaria - Laveran To Genomics
11. UK Govt Says On Course For National Chlamydia Screening
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2008)...a, Maryland and D.C. AIDS Offices , , WASHI...y, Washington, D.C. ranks first in AIDS cases. Of...frican American. In an effort to increase awarene...iving Quilt roundtable at the George Washington U...ginia, Maryland and District of Columbia AIDS offi...
(Date:12/4/2008)...acturers A Way to Improve Toy Safety by Meeting th... Improvement Act , , ANN ARBOR, Mich., Dec....ontinue to generate concerns among consumers about...the importance of toy testing. The NSF Toy Safety ... include auditing, testing and assessment. This te...
(Date:12/4/2008)...Veterans , , WASHINGTON, Dec. 4 /PRNewswire...o world-class health care under a Department of Ve... clinics in 16 states. , , Secretary of V... VA will establish new clinics in Alabama, Arkansa... Iowa, Maryland, Michigan, Minnesota, Mississippi,...
(Date:12/4/2008)...e to couples , , THURSDAY, Dec. 4 (Heal...rican women who have finished fertility treatments... the disposal of unused embryos created with their... were very unlikely to choose to allow the frozen ...r women, given to researchers, or frozen "forever....
Breaking Medicine News(10 mins):Health News:Southern AIDS Living Quilt Raises Awareness in Washington, D.C. 2Health News:Southern AIDS Living Quilt Raises Awareness in Washington, D.C. 3Health News:NSF International Offers Answers to Rising Toy Safety Concerns 2Health News:VA Opening 31 New Outpatient Clinics 2Health News:Women Unhappy With Disposal Options After Infertility Treatment 2Health News:Women Unhappy With Disposal Options After Infertility Treatment 3
...cientists have developed a test that can detect th... Researchers led by Arieh Yaari of Soroka Univers... study on 37 dialysis patients, people without kid...ssed through a machine to filter out waste product...
...ohol hangovers cannot be cured by taking medicatio...urnal. Researchers have found from review of eight...hic medicines have no cure in reducing hangovers w... common hangover symptoms are headache, nausea, vo...
...tudy conducted at Oregon Health & Science Universi...as revealed that a perfect molecular mixture prese...l period of sexual activity and increased aggressi...other surrounding male competitors and influences ...
...dy published in the December 21 issue of the Journ...sure to ultraviolet B (UV-B) radiation reduces the...d to the skin and hence increases the risk of deve... cell carcinoma. UV radiation is the commonest ca...
Other Medicine News:Health News:The Chemistry Of Sexual Attraction Between Male And Female Elephants 2
(Date:12/2/2008)...ire-USNewswire/ -- Researchers using functional,M...e area of the brain,responsible for suppressing m...,stress-related psychiatric disorders. Results of ...eeting of the Radiological Society of North Americ...ssion and other stress-related disorders,traumat...
(Date:12/2/2008)... Biopure Corporation,(N...l Medical Research Center,(NMRC) has submitted to...,investigational new drug (IND) application to con...rapeutic Hemopure(R) [hemoglobin glutamer - 250 (b...t of trauma patients. The study is,entitled "Oper...
(Date:12/2/2008)... TorreyPines Therapeutics, Inc. (N...rom a 26 patient Phase II trial evaluating three d...ry mouth, in patients with Sjogren,s syndrome. NG...ignificant increase in salivary flow production co..., and 20 mg. These doses were safe and well tolera...
(Date:12/2/2008)...RNewswire-FirstCall/ -- Micromet, Inc. (Nasdaq: ...el, proprietary antibodies for the treatment of ca...announced that it has entered into an agreement ex...EFF) with Kingsbridge Capital Limited, a private i..., Kingsbridge has committed to provide up to $75 m...
Breaking Medicine Technology:Stress-Related Disorders Affect Brain's Processing of Memory 2Stress-Related Disorders Affect Brain's Processing of Memory 3U.S. Naval Medical Research Center Resubmits IND Application for Proposed 'Op RESUS' Clinical Trial in Trauma Patients in the Battlefield Setting 2U.S. Naval Medical Research Center Resubmits IND Application for Proposed 'Op RESUS' Clinical Trial in Trauma Patients in the Battlefield Setting 3TorreyPines Therapeutics Muscarinic Agonist NGX267 Meets Primary Endpoint in a Phase II Clinical Trial in Patients with Xerostomia 2TorreyPines Therapeutics Muscarinic Agonist NGX267 Meets Primary Endpoint in a Phase II Clinical Trial in Patients with Xerostomia 3TorreyPines Therapeutics Muscarinic Agonist NGX267 Meets Primary Endpoint in a Phase II Clinical Trial in Patients with Xerostomia 4TorreyPines Therapeutics Muscarinic Agonist NGX267 Meets Primary Endpoint in a Phase II Clinical Trial in Patients with Xerostomia 5Micromet Expands Committed Equity Financing Facility to $75 Million 2Micromet Expands Committed Equity Financing Facility to $75 Million 3Micromet Expands Committed Equity Financing Facility to $75 Million 4Micromet Expands Committed Equity Financing Facility to $75 Million 5Micromet Expands Committed Equity Financing Facility to $75 Million 6Caring Give Back A Smile Volunteer Dental Professionals Donate Over 245 Million in Services to Survivors of Domestic Violence 11827 1Caring Give Back A Smile Volunteer Dental Professionals Donate Over 245 Million in Services to Survivors of Domestic Violence 11827 2Great Ape Trust signs agreement with Universitas Nasional in Jakarta 2192 1Great Ape Trust signs agreement with Universitas Nasional in Jakarta 2192 2Great Ape Trust signs agreement with Universitas Nasional in Jakarta 2192 3Great Ape Trust signs agreement with Universitas Nasional in Jakarta 2192 4Great Ape Trust signs agreement with Universitas Nasional in Jakarta 2192 5U of I study 3A exercise to avoid gallstones 21 11822 1U of I study 3A exercise to avoid gallstones 21 11822 2National Council on Disability to Make Recommendations on Youth with Disabilities in the Foster Care System 11819 1National Council on Disability to Make Recommendations on Youth with Disabilities in the Foster Care System 11819 2
...BUSINESS WIRE)--Apr 25, 2007 - BioDelivery,Science...ay,statistically significant results with BEMA(TM)...n in its pivotal Phase III efficacy,clinical trial...ment of the primary efficacy endpoint of the trial...pared to placebo., The results demonstrated that p...
...; April 25, 2007 - Genmab A/S (CSE: GEN),announced...fatumumab (HuMax-CD20™) in patients with rhe... presentation at the 2007,Annual European Congress...hich will include new results from the double-blin...ab, along with data,from the previous interim anal...
Other Medicine Technology:BDSI Announces Positive Phase III Clinical Trial Results for BEMA,Fentanyl 2BDSI Announces Positive Phase III Clinical Trial Results for BEMA,Fentanyl 3BDSI Announces Positive Phase III Clinical Trial Results for BEMA,Fentanyl 4BDSI Announces Positive Phase III Clinical Trial Results for BEMA,Fentanyl 5BDSI Announces Positive Phase III Clinical Trial Results for BEMA,Fentanyl 6
As part of a new modular Endourological Platform concept, the Sonolith Praktis combines the latest technology developped in extracorporeal lithotripsy: electroconductivity, with a compact and innovat
Used for temporary control of male urinary incontinence due to surgery or neurogenic disorder. Supplied non-sterile. Reusable. Intended for single patient use only.
Used for male external catheterization due to urinary incontinence. The inflatable retention ring secures the catheter and can be easily deflated for removal. Supplied non-sterile. Reusable. Intended
The latex free, hydrophilic Self-Cath Plus is designed for single use, intermittent self-catheterization. The unique hydrophilic coating activates immediately upon exposure to water for fast, clean
Medicine Products: